EUVIMEDEUVIMED entdecken
Crossref

Real-world outcomes of diffuse large B-cell lymphoma treated with frontline R-CHOP(-like) regimens in an Asian multi-ethnic population

Ryan Mao Heng Lim, Jing Yuan Tan, Ya Hwee Tan, Zane En Qi Heng, Lawrence Cheng Kiat Ng, Francesca Lorraine Wei Inng Lim, Yeow Tee Goh, Soon Thye Lim, Jason Yongsheng Chan

Annals of Hematology · 2024

DOI: 10.1007/s00277-024-06067-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Hematology, 2024. Verfasst von Ryan Mao Heng Lim und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medical Oncology, National Cancer Centre Singapore, 30 Hospital Blvd, Singapore, 168583, Singapore. Hauptthemen laut MEDLINE: Lymphoma, Large B-Cell, Diffuse, Antineoplastic Combined Chemotherapy Protocols, Cyclophosphamide, Doxorubicin. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: National Medical Research Council, SingHealth Duke-NUS AM/ACP-Designated Philanthropic Fund Grant Award, Tanoto Foundation Professorship in Medical Oncology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphoma, Large B-Cell, DiffuseAntineoplastic Combined Chemotherapy ProtocolsCyclophosphamideDoxorubicinRituximabVincristinePrednisoneAsian PeopleHumansMaleFemaleMiddle AgedAgedRetrospective StudiesAdultAged, 80 and overSingaporeYoung AdultTreatment OutcomeSurvival RateDisease-Free Survival

Stichwörter der Autor:innen

Bispecific antibodyCAR-T cellsCell-of-originDouble-hitPolatuzumab vedotin

Substanzen

CyclophosphamideDoxorubicinRituximabVincristinePrednisoneR-CHOP protocol

Autor:innen und Institutionen

  • Division of Medical Oncology, National Cancer Centre Singapore, 30 Hospital Blvd, Singapore, 168583, Singapore.
  • Department of Haematology, Singapore General Hospital, Singapore, Singapore.
  • Duke-NUS Medical School, Singapore, Singapore.
  • Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Division of Medical Oncology, National Cancer Centre Singapore, 30 Hospital Blvd, Singapore, 168583, Singapore. jason.chan.y.s@nccs.com.sg.
  • Duke-NUS Medical School, Singapore, Singapore. jason.chan.y.s@nccs.com.sg.

Förderung

  • National Medical Research Council
  • SingHealth Duke-NUS AM/ACP-Designated Philanthropic Fund Grant Award
  • Tanoto Foundation Professorship in Medical Oncology
  • New Century Foundation Limited
  • Ling Foundation

Zitieren

APA

Lim, R. M. H., Tan, J. Y., Tan, Y. H., Heng, Z. E. Q., Ng, L. C. K., Lim, F. L. W. I., Goh, Y. T., Lim, S. T., & Chan, J. Y. (2024). Real-world outcomes of diffuse large B-cell lymphoma treated with frontline R-CHOP(-like) regimens in an Asian multi-ethnic population. Annals of Hematology. https://doi.org/10.1007/s00277-024-06067-2

Vancouver

Lim RMH, Tan JY, Tan YH, Heng ZEQ, Ng LCK, Lim FLWI, et al. Real-world outcomes of diffuse large B-cell lymphoma treated with frontline R-CHOP(-like) regimens in an Asian multi-ethnic population. Annals of Hematology. 2024. doi:10.1007/s00277-024-06067-2

BibTeX
@article{Lim2024,
  author = {Lim, Ryan Mao Heng and Tan, Jing Yuan and Tan, Ya Hwee and Heng, Zane En Qi and Ng, Lawrence Cheng Kiat and Lim, Francesca Lorraine Wei Inng and Goh, Yeow Tee and Lim, Soon Thye and Chan, Jason Yongsheng},
  title = {Real-world outcomes of diffuse large B-cell lymphoma treated with frontline R-CHOP(-like) regimens in an Asian multi-ethnic population},
  journal = {Annals of Hematology},
  year = {2024},
  doi = {10.1007/s00277-024-06067-2}
}
Kostenlos starten →